Global Trust Asset Management LLC Buys 1,700 Shares of CME Group Inc (CME)
Global Trust Asset Management LLC raised its stake in shares of CME Group Inc (NASDAQ:CME) by 5,666.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,730 shares of the financial services provider’s stock after purchasing an additional 1,700 shares during the period. Global Trust Asset Management LLC’s holdings in CME Group were worth $325,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Private Trust Co. NA lifted its holdings in shares of CME Group by 1.9% during the 4th quarter. Private Trust Co. NA now owns 3,488 shares of the financial services provider’s stock valued at $656,000 after purchasing an additional 66 shares during the last quarter. Rehmann Capital Advisory Group boosted its holdings in CME Group by 5.4% in the 3rd quarter. Rehmann Capital Advisory Group now owns 1,650 shares of the financial services provider’s stock worth $281,000 after buying an additional 85 shares during the last quarter. WealthPLAN Partners LLC boosted its holdings in CME Group by 14.6% in the 3rd quarter. WealthPLAN Partners LLC now owns 1,908 shares of the financial services provider’s stock worth $367,000 after buying an additional 243 shares during the last quarter. Welch Group LLC lifted its stake in CME Group by 18.6% in the 4th quarter. Welch Group LLC now owns 1,589 shares of the financial services provider’s stock worth $299,000 after purchasing an additional 249 shares in the last quarter. Finally, First Citizens Bank & Trust Co. lifted its stake in CME Group by 1.4% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 20,939 shares of the financial services provider’s stock worth $3,564,000 after purchasing an additional 295 shares in the last quarter. 85.73% of the stock is owned by hedge funds and other institutional investors.
NASDAQ CME traded up $0.72 during trading hours on Friday, hitting $180.57. 57,947 shares of the stock were exchanged, compared to its average volume of 1,905,944. The stock has a market capitalization of $60.69 billion, a P/E ratio of 37.77, a P/E/G ratio of 2.21 and a beta of 0.43. CME Group Inc has a 12-month low of $149.38 and a 12-month high of $197.08. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.15.
The company also recently declared a dividend, which will be paid on Wednesday, January 16th. Investors of record on Friday, December 28th will be issued a dividend of $1.75 per share. The ex-dividend date of this dividend is Thursday, December 27th. CME Group’s dividend payout ratio is currently 58.70%.
In other CME Group news, Director Charles P. Carey sold 2,800 shares of the company’s stock in a transaction dated Friday, November 2nd. The shares were sold at an average price of $183.45, for a total transaction of $513,660.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO John W. Pietrowicz sold 17,960 shares of the company’s stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the transaction, the chief financial officer now owns 44,780 shares in the company, valued at $8,370,277.60. The disclosure for this sale can be found here. Insiders have sold 58,647 shares of company stock valued at $11,107,550 over the last three months. 0.43% of the stock is currently owned by corporate insiders.
A number of brokerages have issued reports on CME. Bank of America reissued a “neutral” rating and issued a $191.00 target price (down previously from $200.00) on shares of CME Group in a research report on Friday. They noted that the move was a valuation call. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Berenberg Bank set a $184.00 price objective on shares of CME Group and gave the company a “hold” rating in a research note on Thursday, September 20th. Citigroup assumed coverage on shares of CME Group in a report on Tuesday, November 20th. They issued a “buy” rating and a $220.00 target price for the company. Finally, Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Tuesday, September 18th. Eight investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. CME Group currently has a consensus rating of “Buy” and a consensus target price of $193.00.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Recommended Story: Why does a company issue an IPO?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.